BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2255 results:

  • 1. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
    Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
    Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
    Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/emt Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma.
    Zuo A; Li J; Weng S; Xu H; Zhang Y; Wang L; Xing Z; Luo P; Cheng Q; Li J; Han X; Liu Z
    J Proteome Res; 2024 May; 23(5):1821-1833. PubMed ID: 38652053
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Re-exploration of immunotherapy targeting emt of hepatocellular carcinoma: Starting from the NF-κB pathway.
    Wang S; He Y; Wang J; Luo E
    Biomed Pharmacother; 2024 May; 174():116566. PubMed ID: 38631143
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
    Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
    PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA NEAT1 in the pathogenesis of liver-related diseases.
    Saleh RO; Alkhafaji AT; Mohammed JS; Bansal P; Kaur H; Ahmad I; Hjazi A; Mohammed IH; Jawad MA; Zwamel AH
    Cell Biochem Funct; 2024 Apr; 42(3):e4006. PubMed ID: 38622913
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved emt in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma.
    Liu J; Li W; Lu R; Xu J; Jiang C; Duan J; Zhang L; Wang G; Chen J
    Oncol Res; 2024; 32(4):717-726. PubMed ID: 38560576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.
    Zhang X; Li S; Song M; Chen Y; Chang L; Liu Z; Dai H; Wang Y; Yang G; Jiang Y; Lu Y
    Oncol Res; 2024; 32(4):679-690. PubMed ID: 38560575
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2.
    Kim HS; Lee YS; Dong SM; Kim HJ; Lee DE; Kang HW; Kim MJ; Park JS
    Oncol Res; 2024; 32(4):615-624. PubMed ID: 38560567
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC.
    Farina A; Tartaglione S; Preziosi A; Mancini P; Angeloni A; Anastasi E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542466
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
    Xu C; Gao X; Ren T; Geng H; Yang K; Huang Y; Zhang W; Hou S; Song A; Zhang Y; Zhao Q
    Pharmacol Res; 2024 May; 203():107142. PubMed ID: 38522759
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis.
    Li N; Yang C; Xia J; Wang W; Xiong W
    Phytomedicine; 2024 Jun; 128():155338. PubMed ID: 38520835
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The crosstalk between cholangiocytes and hepatic stellate cells promotes the progression of epithelial-mesenchymal transition and periductal fibrosis during Clonorchis sinensis infection.
    Yi J; Jeong JH; Won J; Chung S; Pak JH
    Parasit Vectors; 2024 Mar; 17(1):151. PubMed ID: 38519993
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
    He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
    Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.
    Guo BL; Zheng QX; Jiang YS; Zhan Y; Huang WJ; Chen ZY
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2050. PubMed ID: 38517478
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
    Hashemi M; Daneii P; Asadalizadeh M; Tabari K; Matinahmadi A; Bidoki SS; Motlagh YSM; Jafari AM; Ghorbani A; Dehghanpour A; Nabavi N; Tan SC; Rashidi M; Taheriazam A; Entezari M; Goharrizi MASB
    Int J Biochem Cell Biol; 2024 May; 170():106566. PubMed ID: 38513802
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
    Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
    Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
    Zheng Y; Li W; Huang Y; Cheng H
    Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
    Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
    Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 113.